Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04315896 |
|
Recruitment Status :
Completed
First Posted : March 20, 2020
Last Update Posted : February 1, 2022
|
Sponsor:
National Institute of Respiratory Diseases, Mexico
Information provided by (Responsible Party):
National Institute of Respiratory Diseases, Mexico
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 1, 2020 |
| Actual Study Completion Date : | August 15, 2020 |